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Book Reviews
Emesis in Anti-Cancer Therapy. Mechanisms and Treatment
Edited by P.R.L. Andrews & G.J. Sanders, London: Chap-
man & Hall Medical, 1993, 256 pp. £52.50.
The advances made during the last decade in the knowledge
of physiology and treatment of radiotherapy and
chemotherapy-induced emesis have been so impressive that a
comprehensive textbook aimed at compiling the vast amount
of information in this field has been long overdue. In this
respect, the book by Andrews and Sanger fulfils an import-
ant gap in medical literature. The contributions of the editors
in the field of antiemetics have been so transcendent that I
believe they are among the most authoritative investigators
to undertake the enterprise of editing such a book.
The book offers many excellent reviews that I am sure will
be highly appreciated by preclinical and clinical investigators
involved or interested in antiemetic therapy. I personally
enjoyed the updates on measurement and mechanisms of
nausea, changes in gastro-intestinal motility associated with
emesis, neurotransmitters and receptors of the emetic path-
way, mechanisms or emesis induced by chemotherapy and
radiotherapy, and pharmacology of antiemetic agents. Many
of the chapters include a significant number of suggestions
and considerations able to generate interesting ideas to be
tested in preclinical and clinical setting. However, no book is
perfect and, as a clinician, I am somewhat critical of the
selection of certain other chapters. Although the authors
stated in the preface that 'the problems of nausea and
vomiting are set in a more general context of anti-cancer
therapy by a detailed study of the pharmacokinetics and
pharmacodinamics of chemotherapeutic drugs and an
examination of their general toxicities', I do not find that this
argument justifies the inclusion of two chapters on such
general topics as 'The pharmacokinetics and pharmaco-
dynamics of chemotherapeutic agents' and 'Toxicology of
chemotherapeutic agents' in a book specifically devoted to
emetic mechanisms and antiemetic therapy. In addition, de-
spite its title, the book devotes just one brief chapter out of
eleven to the practical management of chemotherapy-induced
emesis. In my opinion, those readers involved in the clinical
treatment of cancer patients would have appreciated a more
detailed analysis of the plethora of problems associated with
the management of nausea and vomiting in the clinical set-
ting. In spite of my reservations concerning some of the
selections, I feel that this book constitutes an excellent and
necessary reference text which should occupy a preferential
place in the library of all those involved in one way or
another in the physiology and management of cancer
treatment-related emesis.
M. Martin
Colorectal Cancer. A Scientific Perspective
A.R. Kinsella, Cambridge: CUP, 1992, 159 pp. £40.00
This short book is the first in the series of Cambridge
monographs on cancer research to review a specific cancer
type. The choice by the editors was an important one, large
bowel cancer is the second commonest cancer in the Western
World, whose mortality has not changed over the last three
decades. It also stands out as a disease that has clinically well
defined premalignant lesions, the adenoma, and that in recent
years there has been enormous strides in our understanding
of the biological basis of carcinogenesis within these entities.
The aim of this book was to bring together the epidemiology,
cell and molecular biology of the disease, together with a
resume of the important clinical features and management
problems. To a great extent it succeeds in this. The only real
difficulty I have with this volume is trying to define who it is
aimed at. The editors would believe that it is for the expert in
the field, but clearly a single author monography such as this
cannot hope to give a comprehensive review over a wide
range of topics that varies through animal models to clinical
and molecular genetics. The book would, however, be an
excellent introduction to the young researcher just starting in
the field, whether they come from a clinical or scientific
background and to the general reader wanting to keep
abreast of the rapid developments in this area. Each of the
chapters are succinct and the avoidance of jargon will make
it attractive for the non-specialist reader. Being an essentially
single author book, there was an evenness about the contents
and the reviews of each aspect of the disease were well
balanced. The chapters relating to the molecular and clinical
aspects were the strongest, reflecting the interests of the
authors. The clinical section, written by Philip Schofield, was
particularly clear and concise.
I would recommend this to scientists who want to under-
stand what the clinical problems are associated with the
management of patients with large bowel cancer.
T.G. Cooke
Combined Radiotherapy and Chemotherapy in Clinical Oncology
Edited by A. Horwich, London: Edward Arnold, 1992,
261 pp. £52.50.
This book is a timely review of a controversial and complex
subject. As we seek to maximise the benefit from the applica-
tion of chemotherapy and radiotherapy in the treatment of
solid tumours, the permutations are endless. It is difficult to
obtain a clear grasp of what has been accomplished in this
field and if there are any clear guidelines for patient manage-
ment. By bringing together well referenced reviews covering
the theoretical background and the clinical experience in
combined chemoradiography treatments, this book provides
a very useful basis for further developments.
The opening chapter, and I think the most important
comment of the book, is an analysis by Peto of the type of
trials that have been undertaken. While his arguments for
large randomised trials are very familiar, the singular absence
of data of this type in the field of combined treatments may
be the major reason why there is so little clarity or obvious
progress in this area.
Three chapters on the theoretical basis of combined
chemo- and radiotherapy follow. These are useful reminders
both of the potential and the risks of this approach. Some of
the analysis is a little impenetrable and relates to laboratory
studies of dubious relevance to clinical practice.
The remainder of the book is devoted to chapters on
combined therapy by disease site written by leading author-
ities in their subspecialties. Most are concise, yet readable
though the chapter on small cell lung cancer is very wordy.
One recurring problem is the use of varying terminology.
When chemotherapy is used as the initial treatment is it
'neoadjuvant', 'pre-emptive', 'primary' or 'up front'?
The challenging conclusion from this book is that a very
large amount of effort has been expended combining a wide
range of protocols yet we have made little progress in
defining the role of combined chemotherapy and radio-
therapy in standard clinical practise. It is difficult to plan
studies that ask the right question and are sufficiently simple
to enable us to recruit large numbers of patients to demon-
strate the small benefits that are likely to accrue from com-
bination therapy.